Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adalimumab”

551 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 551 results

Large-scale testing (Phase 3)Study completedNCT00870467
What this trial is testing

Adalimumab in Japanese Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Abbott 334
Early research (Phase 1)Study completedNCT04018599
What this trial is testing

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Who this might be right for
Rheumatoid ArthritisPolyarticular Juvenile Idiopathic ArthritisPsoriatic Arthritis+8 more
Fresenius Kabi SwissBioSim GmbH 216
Large-scale testing (Phase 3)Study completedNCT02581345
What this trial is testing

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque PsoriasisPsoriasis
Momenta Pharmaceuticals, Inc. 572
Testing effectiveness (Phase 2)UnknownNCT02456363
What this trial is testing

Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Chung Shan Medical University 300
Large-scale testing (Phase 3)Study completedNCT00195819
What this trial is testing

Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Abbott 82
Post-approval studies (Phase 4)Study completedNCT02557100
What this trial is testing

Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 80
Post-approval studies (Phase 4)Ended earlyNCT01783015
What this trial is testing

Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate

Who this might be right for
Rheumatoid Arthritis
Pfizer 16
Post-approval studies (Phase 4)Not Yet RecruitingNCT05105347
What this trial is testing

Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's Uveitis

Who this might be right for
Uveitis
Peking Union Medical College Hospital 130
Testing effectiveness (Phase 2)WithdrawnNCT00690911
What this trial is testing

Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis

Who this might be right for
Sarcoidosis
Wake Forest University
Post-approval studies (Phase 4)Study completedNCT02814175
What this trial is testing

Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)

Who this might be right for
Psoriatic Arthritis
AbbVie 246
Post-approval studies (Phase 4)Study completedNCT01556672
What this trial is testing

Adalimumab-psoriasis and Small Bowel Lesions

Who this might be right for
Plaque PsoriasisCrohn's Disease
Innovaderm Research Inc. 100
Post-approval studies (Phase 4)Ended earlyNCT01283971
What this trial is testing

RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 96
Large-scale testing (Phase 3)WithdrawnNCT01674413
What this trial is testing

Calprotectin-Directed Humira® Maintenance Therapy (CADHUM)

Who this might be right for
Crohn's Disease
Peter Higgins
Early research (Phase 1)Study completedNCT03254810
What this trial is testing

Comparison of the Safety and PK of SYN060 to Humira® in Healthy Adult Subjects

Who this might be right for
Arthritis, Rheumatoid
Synermore Biologics Co., Ltd. 94
Post-approval studies (Phase 4)Ended earlyNCT04131322
What this trial is testing

Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease.

Who this might be right for
Crohn DiseaseUlcerative Colitis
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 24
Early research (Phase 1)Study completedNCT04439929
What this trial is testing

Comparative Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of Adalimumab in Healthy Subjects

Who this might be right for
Healthy Participants
Turgut İlaçları A.Ş. 168
Early research (Phase 1)Study completedNCT03849313
What this trial is testing

Pharmacokinetics, Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab)

Who this might be right for
Healthy Volunteers
Alvotech Swiss AG 390
Large-scale testing (Phase 3)Study completedNCT00235820
What this trial is testing

Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 271
Large-scale testing (Phase 3)Study completedNCT01550965
What this trial is testing

Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Who this might be right for
Ulcerative Colitis
AbbVie (prior sponsor, Abbott) 463
Not applicableStudy completedNCT01202565
What this trial is testing

Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 506
Load More Results